ESC 365 - Hurdles and consequences of cardiovascular drug adherence and persistence

ESC Professional Premium Access

Hurdles and consequences of cardiovascular drug adherence and persistence

Session: Cardiovascular drug adherence and persistence: relevance and implementation

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor A. Banerjee (London, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Amitava Banerjee

University College London, London (United Kingdom of Great Britain & Northern Ireland)

6 presentations

1 follower

3 more presentations in this session

Fixed-dose combination drugs in hypertension

Speaker: Professor M. Muiesan (Brescia, IT)

Polypill and atherothrombosis

Speaker: Professor S. Anand (Hamilton, CA)

Perspectives: molecular polypills

Speaker: Professor A. Baker (Edinburgh, GB)

Access the full session

Cardiovascular drug adherence and persistence: relevance and implementation

Speakers: Professor A. Banerjee, Professor M. Muiesan, Professor S. Anand, Professor A. Baker

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources